Department of Surgery, Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Department of Surgical Nursing, Faculty of Nursing, Prince of Songkla University, Songkhla, Thailand.
Asian Pac J Cancer Prev. 2021 Dec 1;22(12):3967-3975. doi: 10.31557/APJCP.2021.22.12.3967.
Rectal cancer is a pervasive type of malignancy that accounts for one-third of colorectal cancers worldwide. Several studies have assessed the use of laparoscopic surgery as a treatment option. However, there is an ongoing debate regarding its oncological safety.
This retrospective study included 270 patients with non-metastatic rectal cancer who underwent either laparoscopic resection (LR, n = 93) or open resection (OR, n = 177) in an academic medical center. The primary outcomes were overall survival (OS) and disease-free survival (DFS), whereas the secondary outcome was postoperative complications. We performed propensity score analyses and compared outcomes. Univariate survival analyses using Kaplan-Meier plots and Cox proportional hazard regression models were also conducted.
In the propensity score matching analyses, 93 LR- and 93 OR-matched patients were compared. The overall median follow-up time was 3.95 years (range, 1.98‒5.55 years). The 3-year OS was similar between the groups (LR 79.1% vs OR 79.2%, p = 0.82). Meanwhile, the DFS rate was also comparable between the groups (LR 77.8% vs OR 73.2%, p = 0.53). No significant differences in operative blood loss or hospital stay between the groups were observed (150 vs 150 mL, p = 0.74; 9 vs 10 days, p = 0.077, respectively). Also, no difference was found in postoperative complications between the groups (p = 0.23). However, LR was associated with a longer operative time than OR (455 vs 356 min, p < 0.001) and the number of lymph nodes harvested in LR was slightly fewer than OR (10 vs 11, p = 0.045).
LR of rectal cancer is safe, feasible, and comparable to standard OR in terms of the oncologic outcomes. However, LR required longer operative times. A well-designed prospective study with a large number of participants and long follow-up period is needed to show significant differences between the two groups.
.
直肠癌是一种普遍存在的恶性肿瘤,占全球结直肠癌的三分之一。几项研究评估了腹腔镜手术作为一种治疗选择。然而,其肿瘤学安全性仍存在争议。
本回顾性研究纳入了在一家学术医疗中心接受腹腔镜切除术(LR,n=93)或开放切除术(OR,n=177)治疗的 270 例非转移性直肠癌患者。主要结局是总生存(OS)和无病生存(DFS),次要结局是术后并发症。我们进行了倾向评分分析,并比较了结果。使用 Kaplan-Meier 图和 Cox 比例风险回归模型进行了单变量生存分析。
在倾向评分匹配分析中,比较了 93 例 LR 和 93 例 OR 匹配患者。总体中位随访时间为 3.95 年(范围,1.98-5.55 年)。两组的 3 年 OS 相似(LR 为 79.1%,OR 为 79.2%,p=0.82)。同时,两组的 DFS 率也相似(LR 为 77.8%,OR 为 73.2%,p=0.53)。两组之间的手术失血量或住院时间无显著差异(150 与 150mL,p=0.74;9 与 10 天,p=0.077)。此外,两组之间的术后并发症发生率也无差异(p=0.23)。然而,LR 的手术时间长于 OR(455 与 356 分钟,p<0.001),LR 中采集的淋巴结数量略少于 OR(10 与 11 个,p=0.045)。
LR 治疗直肠癌安全、可行,在肿瘤学结局方面与标准 OR 相当。然而,LR 需要更长的手术时间。需要一项设计良好的、有大量参与者和长期随访的前瞻性研究来显示两组之间的显著差异。